Answer Happy

Question 9 1 pts Which of the following statements about recombinant human erythropoietin (rHuEPO) is correct? First-generation rHuEPO is more beneficial for patients with anaemia because of the drugs shorter half-life. OrHuEPO enhances aerobic performance by elevating levels of endogenous EPO. O As a protein, rHuEPO has good oral bioavailability. O Differences in glycosylation patterns between endogenous and recombinant EPO can be used to detect rHuEPO doping in athletes. Question 10 1 pts Which one of the following effects would most likely not be inhibited by a non-steroidal anti- inflammatory drug (NSAID)? O TXA2-induced activation of platelet aggregation. O PG12-induced vasodilation. OPGI2-induced inhibition of platelet aggregation. LTC4-induced constriction of bronchial smooth muscle.